What's next after the UiPath stock crash? A recovery could be imminent as UiPath's quarterly results include some notable positive points. More
Articles
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024
BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. More
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?
Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares. More
TSM Forecast: Don’t Let the Vertical Price Move in Taiwan Semiconductor Stock Scare You
Taiwan Semiconductor stock remains a terrific AI-chip sector investment as Taiwan Semiconductor plans to buy back millions of its own shares. More
Alphabet Stock: From A to Z, Here’s Why You Should Let GOOG Ride
Alphabet stock has once again hit new 52-week highs, but before you take profit, take into account its myriad of catalysts. More
There’s No Need to ‘Split’ from Nvidia Stock Just Yet
With Nvidia stock, be less concerned about locking in gains, as substantial upside remains on the table for this AI winner. More
